ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02269917
Brief Title: Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

First Submitted : October 17, 2014
First Submitted that Met QC Criteria : October 17, 2014
First Posted : October 21, 2014 (Estimate)

Results First Submitted : August 14, 2018
Results First Submitted that Met QC Criteria : November 8, 2018
Results First Posted : November 9, 2018

Certification/Extension First Submitted : February 8, 2018
Certification/Extension First Submitted that Met QC Criteria : February 8, 2018
Certification/Extension First Posted : February 12, 2018

Last Update Submitted that Met QC Criteria : November 8, 2018
Last Update Posted : November 9, 2018